SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.

Document Details

Form

Filing Date

October 20, 2017

Document Date

October 20, 2017

Filing Group

Other

Company

Prelude Therapeutics

Issuer

PRELUDE THERAPEUTICS INC

Filing Formats

View HTML

Print Page

RSS Feeds

Email Alerts

Search